Swiss Life Asset Management Ltd reduced its stake in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 64.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,843 shares of the company’s stock after selling 8,828 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Molina Healthcare were worth $840,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Torren Management LLC bought a new position in Molina Healthcare during the fourth quarter valued at about $26,000. Miller Global Investments LLC bought a new position in shares of Molina Healthcare in the fourth quarter worth about $27,000. MUFG Securities EMEA plc bought a new position in shares of Molina Healthcare in the second quarter worth about $48,000. Cromwell Holdings LLC increased its stake in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the period. Finally, Rakuten Securities Inc. increased its stake in shares of Molina Healthcare by 5,020.0% in the fourth quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock worth $44,000 after purchasing an additional 251 shares during the period. 98.50% of the stock is currently owned by institutional investors.
Molina Healthcare Stock Down 1.1%
MOH stock opened at $184.78 on Friday. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $327.68. The company has a market cap of $9.63 billion, a PE ratio of 54.67 and a beta of 0.85. The business’s 50-day simple moving average is $156.96 and its 200 day simple moving average is $158.90. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on MOH. Wells Fargo & Company lifted their price objective on Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a research note on Monday, April 27th. Barclays lifted their price objective on Molina Healthcare from $133.00 to $161.00 and gave the stock an “underweight” rating in a research note on Friday, April 24th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $129.00 price objective on shares of Molina Healthcare in a research note on Friday, April 24th. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a research note on Wednesday, April 29th. Finally, Robert W. Baird lifted their price objective on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $174.53.
View Our Latest Stock Report on Molina Healthcare
Insider Transactions at Molina Healthcare
In related news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by company insiders.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Stories
- Five stocks we like better than Molina Healthcare
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
